Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice

Blood

Volumn 90, Issue 9, 1997, Pages 3781-3788

  Brasel, Kenneth ^a   McKenna, Hilary J ^a   Charrier, Keith ^a   Morrissey, Phillip J ^a   Williams, Douglas E ^a   Lyman, Stewart D ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOPENIA; FEMALE; HEMATOPOIETIC STEM CELL; LEUKOCYTE COUNT; MOUSE; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030736703     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3781     Document Type: Article

References (38)

1. Juttner CA, To LB, Ho JQK, Bardy PG, Dyson PC, Haylock DN, Kimber RJ: Early lympho-hematopoietic recovery after autografting using peripheral blood stem cells in acute nonlymphoblastic leukemia. Transplant Proc 20:40, 1988
2. Kessinger A, Armitage JO: The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77:211, 1991
3. Craddock CF, Apperley JF, Wright EG, Healy LE, Bennett CA, Evans M, Grimsley PG, Gordon MY: Circulating stem cells in mice treated with cyclophosphamide. Blood 80:264, 1992
4. Turella C, Boecadoro M, Omedé P, Bondesan P, Caracciolo D, Frieri R, Bregni M, Siena S, Gianni AM, Pileri A: Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma. Bone Marrow Transplant 11:271, 1993
5. - subpopulaiion from mobilized peripheral blood. Blood 85:368, 1995
6. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hardwick A, Moubayed M, Oldham F, Corringham RET, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 85:275, 1995
7. Bungart B, Loeffler M, Goris H, Dontje B, Diehl V, Nijhof W: Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br J Haematol 76:174, 1990
8. Roberts AW, Metcalf D: Granulocyte colony-stimulating factor induces selective elevations of progenitor cells in the peripheral blood of mice. Exp Hematol 22:1156, 1994
9. Briddell RA, Hartley CA, Smith KA, McNiece IK: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720, 1993
10. Jackson JD, Yan Y, Brunda MJ, Kelsey LS, Talmadge JE: Interleukin-12 enhances peripheral hematopoiesis in vivo. Blood 85:2371, 1995
11. Grzegorzewski K, Komschlies KL, Mori M, Kaneda K, Usui N, Faltynek CR, Keller JR, Ruscetti FW, Wiltrout RH: Administration of recombinant human interleukin-7 to mice induces the exportation of myeloid progenitor cells from the bone marrow to peripheral sites. Blood 83:377, 1994
12. Lord BI, Woolford LB, Wood LM, Czaplewski LG, McCourt M, Hunter MG, Edwards RM: Mobilization of early hematopoietic progenitor cells with BB-10010: A genetically engineered variant of human macrophage inflammatory protein-1α. Blood 85:3412, 1995
13. Laterveer L, Lindley IJD, Hamilton MS, Willemze R, Fibbe WE: Interleukin-8 induces rapid mobilization of hematpoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 85:2269, 1995
14. Lyman SD, James L, Vanden Bos T, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FA, Maraskovsky E, Farrah T, Foxworthe D, Williams DE, Beckmann MP: Molecular cloning of a Hgand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 75:1157, 1993
15. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann MP, McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83:2795, 1994
16. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Keiner G, Namikawa R, Rennick D, Roncarolo M-G, Zlotnik A, Rosnet O, Dubreuil P, Birnbaum D, Lee F: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643, 1994
17. Brasel K, Escobar S, Anderberg R, de Vries P, Gruss H-J, Lyman SD: Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia 9:1212, 1995
18. Meierhoff G, Dehmel U, Gruss H-J, Rosnet O, Birnbaum D, Quemmeier H, Dirks W, Drexler HG: Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia 9:1368, 1995
19. Rosnet O, Marcheuo S, deLapeyriere O, Birnbaum D: Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. Oncogene 6:1641, 1991
20. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR: A receptor tyrosine kinase specific to hematopoietio stem and progenitor cell-enriched populations. Cell 65:1143, 1991
21. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459, 1994
22. Hudak S, Hunte B, Culpepper J, Menon S, Hannum C, Thompson-Snipes L, Rennick D: FLT3/FLK2 ligand promotes the growth of marine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood 85:2747, 1995
23. Jacobsen SEW, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD: The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: Synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 181:1357, 1995
24. Hirayama F, Lyman SD, Clark SC, Ogawa M: The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood 85:1762, 1995
25. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR: Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147, 1995
26. Brasel K, McKenna HJ, Morrissey PJ, Charrier K, Morris AE, Lee CC, Williams ED, Lyman SD: Hematological effects of FLT3 ligand in vivo in mice. Blood 88:2004, 1996
27. Price V, Mochizuki D, March CJ, Cosman D, Deeley MC, Klinke R, Clevenger W, Gillis S, Baker P, Urdal D: Expression, purification and characterization of recombinant murine granulocytemacrophage colony-stimulating factor and bovine interleukin-2 from yeast. Gene 55:287, 1987
28. Shen FW, Tung JS, Boyse EA: Further definition of the Ly-5 system. Immunogenetics 24:146, 1986
29. Broxmeyer HE, Williams DE, Cooper S, Shadduck RK, Gillis S, Waheed A, Urdal DL, Bicknell DC: Comparitive effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J Clin Invest 79:721, 1987
30. To LB, Roberts MM, Haylock DN, Dyson PG, Branford AL, Thorp D, Ho JQK, Dart GW, Horvath N, Davy MLJ, Olweny CLM, Abdi E, Juttner CA: Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9:277, 1992
31. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD: Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 71:723, 1988
32. Antin JH, Graft-versus leukemia: No longer a epiphenomenon. Blood 82:2273, 1993
33. Russell JA, Bowen T, Brown C, Luider J, Ruether JD, Stewart D, Jorgenson K, Coppes MJ, Turner AR, Larratt L, Chaudhry A, Booth K, Poon P-C, Klassen J: Second allogeneic transplants for leukemia using blood instead of bone marrow as a source of hematopoietic cells. Bone Marrow Transplant 18:501, 1996
34. Klumpp TR: Complications of peripheral blood stem cell transplantation. Semin Oncol 22:263, 1995
35. Roberts AW, Foote S, Alexander WS, Scott C, Robb L, Metcalf D: Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood 89:2736, 1997
36. Sudo Y, Shimazaki C, Ashihara E, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N, Nakagawa M: Synergistic effect of flt-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into the blood of mice. Blood 89:3186, 1997
37. Molineux G, McCrea C, Yan XQ, Kerzic P, McNiece I: Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential. Blood 89:3998, 1997
38. Winton EF, Bucur SZ, Bond LD, Hegwood AJ, Hillyer CD, Holland HK, Williams DE, McClure HM, Troutt AB, Lyman SD: Recombinant human (rh) flt3 ligand plus rhGM-CSF or rhG-CSF causes a marked CD34+ cell mobilization to blood in rhesus monkeys. Blood 88:642a, 1996 (abstr, suppl 1)